NBSSX
Price
$31.08
Change
+$0.20 (+0.65%)
Updated
Dec 24 closing price
NPFCX
Price
$59.28
Change
+$0.52 (+0.88%)
Updated
Dec 24 closing price
Ad is loading...

NBSSX vs NPFCX

Header iconNBSSX vs NPFCX Comparison
Open Charts NBSSX vs NPFCXBanner chart's image
Neuberger Berman Focus Investor
Price$31.08
Change+$0.20 (+0.65%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective C
Price$59.28
Change+$0.52 (+0.88%)
VolumeN/A
CapitalizationN/A
NBSSX vs NPFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NBSSX vs. NPFCX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBSSX is a Buy and NPFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 146B vs. NBSSX (739M). NBSSX pays higher dividends than NPFCX: NBSSX (0.53) vs NPFCX (0.20). NBSSX was incepted earlier than NPFCX: NBSSX (69 years) vs NPFCX (24 years). NBSSX is a more actively managed with annual turnover of: 78.00 vs. NPFCX (17.00). NPFCX has a lower initial minimum investment than NBSSX: NPFCX (250) vs NBSSX (1000). NBSSX annual gain was more profitable for investors over the last year : 24.96 vs. NPFCX (13.85). NPFCX return over 5 years is better than : 30.89 vs. NBSSX (23.78).
NBSSXNPFCXNBSSX / NPFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence69 years24 years-
Gain YTD24.30913.173185%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets739M146B1%
Annual Yield % from dividends0.530.20267%
Returns for 1 year24.9613.85180%
Returns for 3 years5.40-4.55-119%
Returns for 5 years23.7830.8977%
Returns for 10 years20.6567.0231%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TUYA1.810.02
+1.12%
Tuya
AB36.800.31
+0.85%
AllianceBernstein Holding LP
ABTS0.45N/A
+0.67%
Abits Group
NVR8259.3736.85
+0.45%
NVR
HRTX1.58-0.02
-1.25%
Heron Therapeutics